The biologic sealants presently available on the market that are used in cardiovascular surgery and particularly during surgery of the aorta are described in this article. Two of these biological sealants, the gelatin-resorcinol-formaldehyde (GRF) glue and two-component fibrin sealant have been in use for two decades. Their respective properties are described beneficial in modifying the natural history of the disease. Certain pharmacological agents that result in improved aortic function have been identified.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0733-8651(05)70114-4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!